星華反光(301077.SZ):擬不超2500萬元競拍杭州市一二類工業用地使用權
格隆匯12月16日丨星華反光(301077.SZ)公佈,公司於2021年12月15日召開了第三屆董事會第二次會議,審議通過了《關於使用自有資金購買土地使用權的議案》,同意公司擬以不超過2,500.00萬元的自有資金競拍《杭州市餘杭區國有建設用地使用權掛牌出讓公吿(杭餘規劃資源吿字[2021]112)號》中地塊編號為餘政工出[2021]12號的土地使用權,具體成交價格以競拍最終結果為準。交易標的的基本情況如下:
宗地坐落:徑山鎮漕橋工業區塊18-2地塊,東至規劃綠化帶,南至規劃次幹路,西至相鄰地界,北至規劃支路。用地性質:二類工業用地(M2);土地面積(m2):20885。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.